Supplementary Figures S1-S4 from Eribulin Induces Irreversible Mitotic Blockade: Implications of Cell-Based Pharmacodynamics for &lt;i&gt;In vivo&lt;/i&gt; Efficacy under Intermittent Dosing Conditions